{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:07:13Z","timestamp":1790989633661,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["NIRG-09-131751"],"award-info":[{"award-number":["NIRG-09-131751"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["P30AG72975"],"award-info":[{"award-number":["P30AG72975"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["U01AG46152"],"award-info":[{"award-number":["U01AG46152"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["U01AG61356"],"award-info":[{"award-number":["U01AG61356"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["P30AG010161"],"award-info":[{"award-number":["P30AG010161"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["R01AG015819"],"award-info":[{"award-number":["R01AG015819"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R03AG070540-01"],"award-info":[{"award-number":["R03AG070540-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AG015819"],"award-info":[{"award-number":["R01AG015819"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30AG72975"],"award-info":[{"award-number":["P30AG72975"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30AG010161"],"award-info":[{"award-number":["P30AG010161"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["AZ160065"],"award-info":[{"award-number":["AZ160065"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.retram.2022.103362","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T02:35:35Z","timestamp":1660185335000},"page":"103362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["APOE \u03b54 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain"],"prefix":"10.1016","volume":"71","author":[{"given":"Claire J.C.","family":"Huguenard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cseresznye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Darcey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Nkiliza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Arvanitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein N.","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2022.103362_bib0001","first-page":"1","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.retram.2022.103362_bib0002","article-title":"Schjeide LMS","author":"Bertram","year":"2010","journal-title":"AlzGene"},{"key":"10.1016\/j.retram.2022.103362_bib0003","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer's disease: progress to date and the path forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.retram.2022.103362_bib0004","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3233\/JAD-201205","article-title":"APOE E2\/E2 is associated with slower rate of cognitive decline with age","volume":"83","author":"Sweigart","year":"2021","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.retram.2022.103362_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.62199","article-title":"Apoe2 is associated with longevity independent of alzheimer's disease","volume":"9","author":"Shinohara","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.retram.2022.103362_bib0006","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.retram.2022.103362_bib0007","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"10.1016\/j.retram.2022.103362_bib0008","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jalz.2018.08.005","article-title":"Understanding disease progression and improving Alzheimer's disease clinical trials: recent highlights from the Alzheimer's Disease neuroimaging initiative","volume":"15","author":"Veitch","year":"2019","journal-title":"Alzheimer's Dement"},{"issue":"7","key":"10.1016\/j.retram.2022.103362_bib0009","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jalz.2015.05.003","article-title":"The Alzheimer's disease neuroimaging initiative 2 biomarker core: a review of progress and plans","volume":"11","author":"Kang","year":"2015","journal-title":"Alzheimer's Dement"},{"issue":"September","key":"10.1016\/j.retram.2022.103362_bib0010","first-page":"1","article-title":"Bridging the gap between fluid biomarkers for Alzheimer's disease, model systems, and patients","volume":"12","author":"Bjorkli","year":"2020","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"10.1016\/j.retram.2022.103362_bib0011","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","article-title":"Cerebral metabolic changes accompanying conversion of mild cognitive impairment into alzheimer's disease: a PET follow-up study","volume":"30","author":"Drzezga","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.retram.2022.103362_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.00150","article-title":"APOE alleles and diet in brain aging and Alzheimer's disease","volume":"12","author":"Yassine","year":"2020","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"10.1016\/j.retram.2022.103362_bib0013","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","article-title":"Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing","volume":"19","author":"Cunnane","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.retram.2022.103362_bib0014","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/ijo.2016.93","article-title":"Metabolic shifts toward fatty-acid usage and increased thermogenesis are associated with impaired adipogenesis in mice expressing human APOE4","volume":"40","author":"Arbones-Mainar","year":"2016","journal-title":"Int J Obes"},{"issue":"30","key":"10.1016\/j.retram.2022.103362_bib0015","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1523\/JNEUROSCI.2262-17.2018","article-title":"Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer's disease risk reduction and early intervention","volume":"38","author":"Wu","year":"2018","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.retram.2022.103362_bib0016","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3945\/ajcn.116.130492","article-title":"Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions","volume":"103","author":"Guasch-Ferr\u00e9","year":"2016","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.retram.2022.103362_bib0017","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2018-01000","article-title":"Plasma acylcarnitines and risk of type 2 diabetes in a mediterranean population at high cardiovascular risk","volume":"104","author":"Guasch-Ferr\u00e9","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.retram.2022.103362_bib0018","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/GIM.0b013e3181614289","article-title":"Acylcarnitine profile analysis","volume":"10","author":"Rinaldo","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.retram.2022.103362_bib0019","series-title":"Vol. 1546, Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology","first-page":"21","article-title":"Molecular enzymology of carnitine transfer and transport","author":"Ramsay","year":"2001"},{"issue":"5\u20136","key":"10.1016\/j.retram.2022.103362_bib0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.mam.2004.06.002","article-title":"Carnitine acyltransferases and their influence on CoA pools in health and disease","volume":"25","author":"Ramsay","year":"2004","journal-title":"Mol Aspects Med"},{"issue":"6","key":"10.1016\/j.retram.2022.103362_bib0021","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00018-008-7576-6","article-title":"Short- and medium-chain carnitine acyltransferases and acyl-CoA thioesterases in mouse provide complementary systems for transport of \u03b2-oxidation products out of peroxisomes","volume":"65","author":"Westin","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.retram.2022.103362_bib0022","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.biochem.74.082803.133329","article-title":"Biochemistry of mammalian peroxisomes revisited","volume":"75","author":"Wanders","year":"2006","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"10.1016\/j.retram.2022.103362_bib0023","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.retram.2022.103362_bib0024","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/bdd.371","article-title":"Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2","volume":"24","author":"Inano","year":"2003","journal-title":"Biopharm Drug Dispos"},{"issue":"5","key":"10.1016\/j.retram.2022.103362_bib0025","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/bcpt.12729","article-title":"Carnitine and \u03b3-butyrobetaine stimulate elimination of meldonium due to competition for OCTN2-mediated transport","volume":"120","author":"Liepinsh","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5\u20136","key":"10.1016\/j.retram.2022.103362_bib0026","first-page":"551","article-title":"Carnitine: transport and physiological functions in the brain","volume":"25","author":"Na\u0142ezcz","year":"2004","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.retram.2022.103362_bib0027","doi-asserted-by":"crossref","unstructured":"Hajjar I, Cai Q, Yu T, Jones D. Untargeted metabolomics shows alterations in homocysteine, lipids and fatty acids predicting memory decline in healthy middle-aged individuals. 2020.","DOI":"10.1101\/2020.02.23.949537"},{"key":"10.1016\/j.retram.2022.103362_bib0028","article-title":"The role of trimethylamine-N-Oxide in the development of Alzheimer's disease","author":"Buawangpong","year":"2021","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.retram.2022.103362_bib0029","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jcmm.13307","article-title":"Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies","volume":"22","author":"Qi","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"8","key":"10.1016\/j.retram.2022.103362_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2021.22844","article-title":"Association of trimethylamine N-Oxide and related metabolites in plasma and incident type 2 diabetes: the cardiovascular health study","volume":"4","author":"Lemaitre","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.retram.2022.103362_bib0031","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jalz.2008.09.004","article-title":"Alzheimer's disease anti-inflammatory prevention trial: design, methods, and baseline results","volume":"5","year":"2009","journal-title":"Alzheimer's Dement"},{"issue":"21","key":"10.1016\/j.retram.2022.103362_bib0032","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/01.wnl.0000260269.93245.d2","article-title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","volume":"68","author":"Lyketsos","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.retram.2022.103362_bib0033","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/clinchem\/37.2.241","article-title":"Analysis of apolipoprotein E genotypes by the amplification refractory mutation system","volume":"37","author":"Wenham","year":"1991","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.retram.2022.103362_bib0034","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of alzheimer's disease: Report of the NINCDS-ADRDA work group\u22c6 under the auspices of department of health and human services task force on alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"SUPPL. 1","key":"10.1016\/j.retram.2022.103362_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S1041610297004717","article-title":"Aging, memory, and mild cognitive impairment","volume":"9","author":"Petersen","year":"1997","journal-title":"Int Psychogeriatrics"},{"issue":"3","key":"10.1016\/j.retram.2022.103362_bib0036","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.retram.2022.103362_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00012","article-title":"Plasma lipidomic analyses in cohorts with mTBI and\/or PTSD reveal lipids differentially associated with diagnosis and APOE \u03b54 carrier status","volume":"11","author":"Huguenard","year":"2020","journal-title":"Front Physiol"},{"issue":"6","key":"10.1016\/j.retram.2022.103362_bib0038","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2174\/156720512801322573","article-title":"Overview and findings from the religious orders study","volume":"9","author":"Bennett","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.retram.2022.103362_bib0039","doi-asserted-by":"crossref","unstructured":"Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA. Religious orders study and rush memory and aging project. Perry G, Avila J, Moreira PI, Sorensen AA, Tabaton M, editors. J Alzheimer's Dis. 2018 Jun 12;64(s1):S161\u201389. Available from: https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-179939","DOI":"10.3233\/JAD-179939"},{"issue":"3","key":"10.1016\/j.retram.2022.103362_bib0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000096129","article-title":"Decision rules guiding the clinical diagnosis of Alzheimer's Disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study","volume":"27","author":"Bennett","year":"2006","journal-title":"Neuroepidemiology"},{"issue":"9","key":"10.1016\/j.retram.2022.103362_bib0041","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The consortium to establish a registry for Alzheimer's DIsease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease","volume":"39","author":"Moms","year":"1989","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.retram.2022.103362_bib0042","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0197-4580(97)00057-2","article-title":"Consensus recommendations for the postmortem diagnosis of Alzheimer's disease","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.retram.2022.103362_bib0043","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.retram.2022.103362_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.03.005","article-title":"Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimer's disease subjects","volume":"43","author":"Ciavardelli","year":"2016","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.retram.2022.103362_bib0045","doi-asserted-by":"crossref","first-page":"R1186","DOI":"10.1152\/ajpregu.00113.2016","article-title":"Fatty acid-induced astrocyte ketone production and the control of food intake","volume":"310","author":"Le Foll","year":"2016","journal-title":"Am J Physiol - Regulatory Integr Compar Physiol"},{"issue":"1","key":"10.1016\/j.retram.2022.103362_bib0046","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12944-019-1044-1","article-title":"Plasmalogens and Alzheimer's disease: a review","volume":"18","author":"Su","year":"2019","journal-title":"Lipids Health Dis"},{"issue":"5","key":"10.1016\/j.retram.2022.103362_bib0047","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3390\/nu12051389","article-title":"Acetyl-L-carnitine in dementia and other cognitive disorders: a critical update","volume":"12","author":"Pennisi","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.retram.2022.103362_bib0048","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/acn3.726","article-title":"A metabolomic approach to identifying biomarkers in blood of Alzheimer's disease","volume":"6","author":"Lin","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.retram.2022.103362_bib0049","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neurobiolaging.2016.11.007","article-title":"What success can teach us about failure: the plasma metabolome of older adults with superior memory and lessons for Alzheimer's disease","volume":"51","author":"Mapstone","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.retram.2022.103362_bib0050","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5472792","article-title":"Amino acid catabolism in Alzheimer's disease brain: friend or foe?","volume":"2017","author":"Griffin","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.retram.2022.103362_bib0051","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2019.10.014","article-title":"Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis","volume":"86","author":"Huo","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.retram.2022.103362_bib0052","first-page":"15","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study","author":"Varma","year":"2018","journal-title":"PLoS Medicine"},{"issue":"0","key":"10.1016\/j.retram.2022.103362_bib0053","first-page":"1","article-title":"Alzheimer's disease and gut microbiota: does trimethylamine N-oxide (TMAO) play a role?","volume":"00","author":"Arrona Cardoza","year":"2021","journal-title":"Nutr Rev"},{"issue":"2","key":"10.1016\/j.retram.2022.103362_bib0054","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0022-510X(97)00314-6","article-title":"Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease","volume":"155","author":"Carlos Rubio","year":"1998","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.retram.2022.103362_bib0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-132063","article-title":"Decreased cerebrospinal fluid levels of L-carnitine in non-apolipoprotein E4 carriers at early stages of Alzheimer's disease","volume":"41","author":"Lodeiro","year":"2014","journal-title":"J Alzheimer's Dis"},{"issue":"6","key":"10.1016\/j.retram.2022.103362_bib0056","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF01705539","article-title":"Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain","volume":"20","author":"Makar","year":"1995","journal-title":"Neurochem Res"},{"issue":"9","key":"10.1016\/j.retram.2022.103362_bib0057","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","article-title":"Metabolic network failures in Alzheimer's disease: A biochemical road map","volume":"13","author":"Toledo","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.retram.2022.103362_bib0058","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1258\/acb.2008.008045","article-title":"Determination of the reference range of endogenous plasma carnitines in healthy adults","volume":"45","author":"Reuter","year":"2008","journal-title":"Ann Clin Biochem"},{"issue":"6","key":"10.1016\/j.retram.2022.103362_bib0059","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0899-9007(97)00031-2","article-title":"Effect of sex and age on bone mass, body composition and fuel metabolism in humans","volume":"13","author":"Horber","year":"1997","journal-title":"Nutrition"},{"issue":"JUL","key":"10.1016\/j.retram.2022.103362_bib0060","first-page":"1","article-title":"The sexual dimorphism of lipid kinetics in humans","volume":"6","author":"Santosa","year":"2015","journal-title":"Front Endocrinol"},{"issue":"12","key":"10.1016\/j.retram.2022.103362_bib0061","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/diab.28.12.1083","article-title":"Plasma and urine carnitine in diabetic ketosis","volume":"28","author":"Genuth","year":"1979","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.retram.2022.103362_bib0062","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bbalip.2014.04.001","article-title":"Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism","volume":"1841","author":"Schooneman","year":"2014","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"issue":"1","key":"10.1016\/j.retram.2022.103362_bib0063","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1172\/JCI94601","article-title":"L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans","volume":"129","author":"Koeth","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.retram.2022.103362_bib0064","first-page":"6","article-title":"Differences between acylcarnitine pro fi les in plasma and bloodspots","author":"Velden","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.retram.2022.103362_bib0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nrneurol.2015.38","article-title":"Dementia: Cognitive resilience in APOE*\u03b54 carriers\u2014is race important?","volume":"11","author":"Barnes","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.retram.2022.103362_bib0066","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamaneurol.2018.4249","article-title":"Assessment of racial disparities in biomarkers for Alzheimer disease","volume":"76","author":"Morris","year":"2019","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.retram.2022.103362_bib0067","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.279.10.751","article-title":"The APOE-\u03b54 Allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics","volume":"279","author":"Tang","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.retram.2022.103362_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.735036","article-title":"The relationship of APOE \u03b54, race, and sex on the age of onset and risk of dementia","volume":"12","author":"Powell","year":"2021","journal-title":"Frontiers in Neurology"},{"issue":"6","key":"10.1016\/j.retram.2022.103362_bib0069","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3945\/jn.108.103754","article-title":"Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid \u03b2-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women","volume":"139","author":"Adams","year":"2009","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.retram.2022.103362_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0155694","article-title":"Serum levels of acyl-carnitines along the continuum from normal to Alzheimer's dementia","volume":"11","author":"Cristofano","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.retram.2022.103362_bib0071","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.retram.2022.103362_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-019-0551-7","article-title":"Systemic and central nervous system metabolic alterations in Alzheimer's disease","volume":"11","author":"Van Der Velpen","year":"2019","journal-title":"Alzheimer's Res Ther"},{"issue":"23","key":"10.1016\/j.retram.2022.103362_bib0073","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1002\/elps.201400196","article-title":"Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry","volume":"35","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2014","journal-title":"Electrophoresis"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318622000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318622000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:25:48Z","timestamp":1778891148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318622000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2452318622000307"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2022.103362","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOE \u03b54 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2022.103362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103362"}}